← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2003Last known activity
Dec 1, 2025
Timeline
2000s
- Jun 1, 2003
German Breast Group Forschungs GmbH— Founded
Drugs by trial phase (49 distinct, 49 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (26 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT07237256CollaboratorPhase 3Dec 1, 2025
- NCT06201234Lead sponsorPhase 2Nov 30, 2024
- NCT06607757Lead sponsorPhase 2Sep 15, 2024
- NCT05306041Lead sponsorPhase 2Jun 30, 2022
- NCT04622319CollaboratorPhase 3Nov 30, 2020
- NCT04595565Lead sponsorPhase 3Oct 28, 2020
- NCT03555877Lead sponsorPhase 2Mar 15, 2018
- NCT03355157Lead sponsorPhase 4Mar 1, 2018
- NCT03355157Study chairPhase 4Mar 1, 2018
- NCT02947685CollaboratorPhase 3Jun 30, 2017
- NCT02682693Lead sponsorPhase 2Feb 13, 2017
- NCT02789332Lead sponsorPhase 2Sep 1, 2016
- NCT02685059Lead sponsorPhase 2Mar 1, 2016
- NCT02387099Lead sponsorPhase 2May 1, 2015
- NCT02125344Lead sponsorPhase 3Dec 1, 2014
Details
- Founded
- Neu-Isenberg, DE Jun 1, 2003
- Last known activity
- Dec 1, 2025
Notes
CRO